Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-17 12:31 pm Purchase |
2021-09-13 | 13G | aTyr Pharma, Inc. ATYR |
TANG CAPITAL PARTNERS LP | 1,063,453 6.300% |
1,063,453 (New Position) |
Filing History |
| 2021-06-21 09:00 am Unchanged |
2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 39.600% |
0 (Unchanged) |
Filing History |
| 2021-06-03 08:30 am Purchase |
2021-05-27 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
TANG CAPITAL PARTNERS LP | 1,350,180 9.990% |
1,350,180 (New Position) |
Filing History |
| 2021-05-27 06:03 am Purchase |
2021-05-26 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 10,126,204 36.800% |
410,714 (+4.23%) |
Filing History |
| 2021-02-16 4:15 pm Sale |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
TANG CAPITAL PARTNERS LP | 7,639,100 7.800% |
-2,110,244 (-21.64%) |
Filing History |
| 2021-02-16 4:15 pm Sale |
2020-12-31 | 13G | Evolus, Inc. EOLS |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-2,635,000 (Position Closed) |
Filing History |
| 2021-02-16 4:15 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
TANG CAPITAL PARTNERS LP | 200,000 1.200% |
-1,100,000 (-84.62%) |
Filing History |
| 2021-02-16 4:15 pm Purchase |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
TANG CAPITAL PARTNERS LP | 2,628,678 9.600% |
784,864 (+42.57%) |
Filing History |
| 2021-02-09 08:30 am Unchanged |
2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 40.200% |
0 (Unchanged) |
Filing History |
| 2020-12-29 4:09 pm Purchase |
2020-12-23 | 13D | Odonate Therapeutics, Inc. ODTC |
TANG CAPITAL PARTNERS LP | 0 41.600% |
0 (+2.31%) |
Filing History |
| 2020-11-19 4:00 pm Purchase |
2008-10-14 | 13G | Heron Therapeutics, Inc. HRTX |
TANG CAPITAL PARTNERS LP | 9,749,344 9.990% |
169,415 (+1.77%) |
Filing History |
| 2020-11-18 5:03 pm Unchanged |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 42.500% |
0 (Unchanged) |
Filing History |
| 2020-11-06 4:52 pm Purchase |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 54.400% |
1,081 (New Position) |
Filing History |
| 2020-09-11 06:02 am Purchase |
2020-09-09 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,715,490 35.400% |
278,369 (+2.95%) |
Filing History |
| 2020-09-01 06:01 am Purchase |
2020-08-28 | 13D | Odonate Therapeutics, Inc. ODTC |
TANG CAPITAL PARTNERS LP | 0 40.600% |
0 (+4.63%) |
Filing History |
| 2020-08-18 06:05 am Purchase |
2020-08-14 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,437,121 34.400% |
431,647 (+4.79%) |
Filing History |
| 2020-06-05 06:04 am Purchase |
2020-06-02 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,005,474 32.900% |
784,899 (+9.55%) |
Filing History |